Are many tests required to diagnose fibromyalgia?

No. Investigations should be guided by the clinical history and physical examination, aiming to exclude inflammatory, endocrine, neurological or other disorders when suggestive clinical findings are present.

What are the main differential diagnoses?

Hypothyroidism, inflammatory rheumatic diseases, polymyalgia rheumatica, myopathies, neuropathies, vitamin deficiencies, depression, sleep disorders and adverse drug effects should be considered.

Which red flags should prompt investigation beyond fibromyalgia?

Unexplained weight loss, fever, night sweats, focal neurological deficits, objective arthritis, progressive muscle weakness, marked inflammatory pain or significant laboratory abnormalities require further investigation.

Is fibromyalgia an inflammatory disease?

No. Fibromyalgia is not a classic systemic inflammatory disease, although it may coexist with inflammatory conditions and amplify the perception of pain and disability.

Is tender-point examination still mandatory?

No. Current criteria focus on pain distribution and overall symptom burden and do not require mandatory tender-point counting.

What is the initial approach after diagnosis?

The initial approach should include a clear explanation of the diagnosis, validation of symptoms, education, gradual exercise, sleep hygiene, management of psychological comorbidities and an individualised treatment plan.

Fibromyalgia: diagnosis and initial assessment

Q: What is fibromyalgia?

Fibromyalgia is a chronic widespread pain syndrome associated with fatigue, unrefreshing sleep, cognitive symptoms and multiple somatic symptoms, without inflammation or structural damage that alone explains the clinical presentation.

Q: How is fibromyalgia diagnosed?

The diagnosis is clinical and is based on the presence of persistent widespread pain, characteristic associated symptoms, functional impact and the exclusion of alternative diagnoses or red flags.

Fibromyalgia is a chronic widespread pain syndrome characterised by persistent musculoskeletal pain, frequently associated with fatigue, sleep disturbances, cognitive symptoms and other somatic complaints. Diagnosis is primarily clinical and requires the exclusion of other conditions that could account for the symptom pattern.
Assessment is based on the 2016 American College of Rheumatology criteria, using the Widespread Pain Index (WPI) and the Symptom Severity Scale (SSS) to support diagnostic confirmation. Once the diagnosis has been established, functional impact should be assessed using the Revised Fibromyalgia Impact Questionnaire (FIQR), allowing disease severity to be quantified, treatment planning to be guided and response to therapy to be monitored over time.

Podcast transcript

Introduction

Fibromyalgia is one of the most common causes of chronic widespread pain in primary care. It is characterised by diffuse musculoskeletal pain, frequently accompanied by fatigue, unrefreshing sleep, cognitive symptoms and multiple somatic complaints. Despite its high prevalence, it remains a challenging condition, both because of its significant impact on quality of life and the absence of specific tests capable of confirming the diagnosis.

Initial assessment

The approach should begin by identifying symptoms compatible with fibromyalgia, particularly widespread pain lasting three months or longer. At this stage, it is essential to exclude other conditions that could explain the clinical presentation, including inflammatory, endocrine, neurological or metabolic disorders. Although there are no diagnostic laboratory tests for fibromyalgia, selected investigations may be useful to rule out alternative diagnoses.

Application of diagnostic criteria

Once other plausible causes have been excluded, the diagnostic criteria of the American College of Rheumatology (ACR) should be applied. The first step is to determine the Widespread Pain Index (WPI), which assesses the number of painful body regions. The Symptom Severity Scale (SSS) is then calculated to quantify the severity of fatigue, cognitive symptoms, sleep disturbances and other associated symptoms.

Diagnostic confirmation

The diagnosis may be established when the WPI is seven or higher and the SSS score is five or higher. Alternatively, the diagnosis may also be confirmed when the WPI is between four and six, provided that the SSS score is nine or higher. In addition to these criteria, pain must be present in at least four of the five body regions defined by the 2016 ACR criteria, and symptoms must have persisted for at least three months.

Assessment of functional impact

After diagnostic confirmation, it is useful to assess the functional impact of the condition using the Revised Fibromyalgia Impact Questionnaire (FIQR). This tool allows disease severity to be quantified, functional limitations to be assessed and clinical progression to be monitored over time.

Therapeutic approach

Regarding treatment, the approach should prioritise non-pharmacological interventions. Patient education, understanding the nature of the condition, promoting regular and progressive physical exercise and improving sleep quality are the main pillars of management. Medication may be considered in selected situations, particularly when symptoms persist despite initial measures, but it should not replace self-management and rehabilitation strategies.

Key message

In summary, the diagnosis of fibromyalgia is primarily clinical and is based on a structured assessment of pain and associated symptoms, after excluding other conditions. The systematic use of the 2016 ACR criteria and the FIQR helps standardise the diagnostic approach, assess disease severity and guide a treatment plan centred on function and quality of life.

Clinical cases

Clinical cases — Fibromyalgia: diagnosis and initial assessment

Case 1 — Widespread pain and persistent fatigue

A 47-year-old woman presents with diffuse musculoskeletal pain lasting for more than 1 year. She reports severe fatigue, unrefreshing sleep and difficulty concentrating. Physical examination shows no synovitis, neurological deficits or other relevant abnormalities. Full blood count, ESR, CRP, TSH and CK are normal.

After applying the 2016 ACR criteria, she has a WPI of 9 and an SSS score of 6.

What is the most appropriate interpretation?

The criteria do not support a diagnosis of fibromyalgia
The criteria are consistent with a diagnosis of fibromyalgia
Magnetic resonance imaging is mandatory for diagnostic confirmation
The diagnosis requires the presence of tender points on palpation

View answer

b) The criteria are consistent with fibromyalgia. Rationale: According to the 2016 ACR criteria, fibromyalgia is supported by a WPI ≥ 7 together with an SSS score ≥ 5, provided that symptoms have been present for at least 3 months and are not better explained by another condition. Tender-point examination is no longer mandatory for diagnosis.

Case 2 — Intermediate pain index

A 52-year-old man presents with widespread pain lasting approximately 6 months, accompanied by fatigue, frequent headaches and sleep disturbances. Initial investigations revealed no relevant abnormalities.

Assessment shows a WPI of 5 and an SSS score of 10.

What is the most appropriate interpretation?

He does not meet the criteria for fibromyalgia
He meets the criteria for fibromyalgia
A psychiatric assessment is mandatory before diagnosis
The diagnosis depends on the presence of associated depression

View answer

b) He meets the criteria for fibromyalgia. Rationale: A WPI between 4 and 6 also supports the diagnosis when associated with an SSS score ≥ 9. In this case, the patient has a WPI of 5 and an SSS score of 10, therefore meeting the ACR diagnostic criteria.

Case 3 — Widespread pain but insufficient criteria

A 39-year-old woman reports widespread muscle pain for 4 months following a period of occupational stress. She has unrefreshing sleep but remains able to perform her usual work activities. Initial laboratory investigations are normal.

Assessment shows a WPI of 3 and an SSS score of 4.

What is the most appropriate approach?

Diagnose fibromyalgia and start specific treatment
Immediately request extensive imaging investigations
Consider alternative diagnoses and reassess clinically
Confirm fibromyalgia using a specific laboratory test

View answer

c) Consider alternative diagnoses. Rationale: The patient does not meet the current diagnostic criteria for fibromyalgia. There are no specific laboratory tests that confirm the condition. When the criteria are not met, alternative causes of the symptoms should be considered and clinical reassessment should be performed according to the subsequent course.

FAQ

Fibromyalgia — Frequently asked questions (FAQ)

1) What is fibromyalgia?

Fibromyalgia is a chronic pain syndrome characterised by widespread musculoskeletal pain, frequently accompanied by fatigue, sleep disturbances, cognitive symptoms (“fibro fog”) and multiple somatic symptoms. It is considered a central sensitisation condition, without identifiable inflammatory or structural damage.

2) How is fibromyalgia diagnosed?

The diagnosis is primarily clinical and is based on the criteria of the American College of Rheumatology (ACR). Assessment includes the Widespread Pain Index (WPI) and the Symptom Severity Scale (SSS), together with the presence of persistent symptoms for at least 3 months.

3) Are there any tests that confirm fibromyalgia?

There are no specific laboratory tests that confirm fibromyalgia. Investigations are mainly used to exclude alternative diagnoses, such as inflammatory, endocrine or metabolic disorders.

4) Which tests are usually recommended?

Depending on the clinical assessment, tests may include a full blood count, ESR, CRP, TSH, creatine kinase (CK) and serum calcium. Other investigations should be reserved for situations in which red flags or suspicion of another condition are present.

5) Are tender points still required for diagnosis?

No. The former tender-point examination is no longer mandatory under current criteria. Diagnosis is now based on the distribution of pain and the overall severity of symptoms reported by the patient.

6) What are the most common symptoms?

In addition to widespread pain, common symptoms include persistent fatigue, unrefreshing sleep, difficulty concentrating, memory problems, headaches, irritable bowel syndrome, anxiety and depression.

7) How is the impact of the condition assessed?

After diagnosis, use of the Revised Fibromyalgia Impact Questionnaire (FIQR) is recommended. This tool assesses function, the overall impact of the condition and symptom severity, thereby supporting clinical monitoring.

8) What is the first-line treatment?

The foundation of treatment is non-pharmacological and includes patient education, regular and progressive physical exercise, improvement of sleep quality and self-management strategies. Aerobic exercise and strength training have the strongest evidence of benefit.

9) Are medicines always necessary?

No. Medication should only be considered when symptoms persist despite non-pharmacological measures. Depending on the clinical profile, medicines such as duloxetine, amitriptyline or pregabalin may be used.

10) Are opioids recommended?

No. Strong opioids are not recommended for the treatment of fibromyalgia because of their limited long-term efficacy and the risks of adverse effects, dependence and worsening pain sensitisation.

11) Is fibromyalgia a progressive condition?

Fibromyalgia does not cause joint destruction or progressive organ damage. However, symptoms may fluctuate over time and can be influenced by factors such as stress, sleep disturbances, physical inactivity or coexisting conditions.

References

Authorship and updates

Submit a Revision

231

23/07/2026

Partial preview of the algorithm for the diagnostic approach to fibromyalgia

Login Required

To access the content, you must log in to the platform.

Go to Login

Algorithm for the diagnostic approach to fibromyalgia

Register

Fibromyalgia: diagnosis and initial assessment

Introduction

Initial assessment

Application of diagnostic criteria

Diagnostic confirmation

Assessment of functional impact

Therapeutic approach

Key message

Clinical cases — Fibromyalgia: diagnosis and initial assessment

Case 1 — Widespread pain and persistent fatigue

Case 2 — Intermediate pain index

Case 3 — Widespread pain but insufficient criteria

Fibromyalgia — Frequently asked questions (FAQ)

1) What is fibromyalgia?

2) How is fibromyalgia diagnosed?

3) Are there any tests that confirm fibromyalgia?

4) Which tests are usually recommended?

5) Are tender points still required for diagnosis?

6) What are the most common symptoms?

7) How is the impact of the condition assessed?

8) What is the first-line treatment?

9) Are medicines always necessary?

10) Are opioids recommended?

11) Is fibromyalgia a progressive condition?

Login Required

Low testosterone levels: differential diagnosis

Erectile dysfunction: approach to differential diagnosis and treatment

Balanitis: approach to differential diagnosis and treatment

Register

Fibromyalgia: diagnosis and initial assessment

Introduction

Initial assessment

Application of diagnostic criteria

Diagnostic confirmation

Assessment of functional impact

Therapeutic approach

Key message

Clinical cases — Fibromyalgia: diagnosis and initial assessment

Case 1 — Widespread pain and persistent fatigue

Case 2 — Intermediate pain index

Case 3 — Widespread pain but insufficient criteria

Fibromyalgia — Frequently asked questions (FAQ)

1) What is fibromyalgia?

2) How is fibromyalgia diagnosed?

3) Are there any tests that confirm fibromyalgia?

4) Which tests are usually recommended?

5) Are tender points still required for diagnosis?

6) What are the most common symptoms?

7) How is the impact of the condition assessed?

8) What is the first-line treatment?

9) Are medicines always necessary?

10) Are opioids recommended?

11) Is fibromyalgia a progressive condition?

Low testosterone levels: differential diagnosis

Erectile dysfunction: approach to differential diagnosis and treatment

Balanitis: approach to differential diagnosis and treatment

algoritMD